Validated Clinical Assessment Tools for Acrophobia

1. Acrophobia Questionnaire (AQ) — Cohen, 1977

• Format: 40-item self-report, divided into two 20-item subscales
• Anxiety subscale: Rates anxiety triggered by 20 height-related situations on a 0–6 Likert scale (0 = not anxious → 6 = extremely anxious); total range 0–120
• Avoidance subscale: Rates behavioral avoidance of each situation on a 3-point scale (0 = "would not avoid it" → 2 = "would not do it under any circumstances"); total range 0–40
• Situations include: Standing on a chair to reach a shelf, riding an elevator to the 50th floor, climbing the gangway to a large ship, looking over a balcony railing, etc.
• Scoring interpretation (Anxiety subscale):

• Psychometric properties: Good reliability and validity; widely used in VR exposure therapy RCTs as a primary outcome measure
• Reference: Cohen DC. Behavior Therapy. 1977;8(1):17–23.

2. Attitudes Towards Heights Questionnaire (ATHQ) — Abelson & Curtis, 1989

• Format: 6 items using semantic differential / adjective pairs (e.g., "Good/Bad," "Safe/Dangerous," "Comfortable/Uncomfortable")
• Scale: 0–10 per item, total range 0–60
• Higher scores indicate more negative/fearful attitudes toward heights
• Use: Sensitive to treatment effects; commonly used as a secondary outcome measure in exposure therapy trials
• Reference: Abelson JL, Curtis GC. Behaviour Research and Therapy. 1989;27(5):561–567.

3. Heights Interpretation Questionnaire (HIQ) — Steinman & Teachman, 2011

• Format: Self-report measuring interpretation bias specific to height-fear-relevant situations
• Factor structure: Four distinct factors (anxiety, danger interpretation, self-efficacy, avoidance expectancy)
• Purpose: Uniquely assesses cognitive processing biases — predicts subjective distress and avoidance beyond self-reported symptom severity
• Clinical use: Useful when assessing the cognitive component of acrophobia, e.g., prior to/after CBT targeting interpretation bias
• Reference: Steinman SA, Teachman BA. Journal of Anxiety Disorders. 2011;25(7):896–902. PMID: 21641766

4. Visual Height Intolerance Severity Scale (vHISS) — Huppert, Grill & Brandt, 2017

• Format: 8-question scale (6 core items + 2 symptom/trigger checklists)
• Scope: Captures a spectrum from physiological height imbalance → visual height intolerance (vHI) → acrophobia
• Scoring: Metric interval scale (not just categorical severity grouping), allowing tracking of dimensional severity over time
• Key distinction: Differentiates vHI (distressing instability when looking from heights, present in ~1 in 3 people) from acrophobia (the clinical phobia, present in ~6% of the population)
• Languages: Available in English and German
• Reference: Huppert D, et al. Frontiers in Neurology. 2017;8:211. PMID: 28620340

5. Behavioural Avoidance Test (BAT)

• The gold-standard objective complement to self-report scales
• Patient is brought into a real (or simulated) height situation and asked to approach/ascend; examiner measures the furthest point reached, latency, and subjective distress units (SUD) at each step
• Captures the self-report/behavior desynchrony (a hallmark of phobias)
• Used in combination with the AQ to validate behavioral change in treatment studies

Summary Comparison

Clinical Notes

• DSM-5 diagnostic threshold: Fear must be out of proportion to actual danger, persist ≥6 months, and cause significant distress or functional impairment.
• The AQ remains the standard primary measure in clinical trials. Most VR exposure therapy RCTs (including those using d-cycloserine augmentation) use the AQ anxiety subscale as their primary endpoint.
• Self-report and behavioral measures frequently show desynchrony — patients may report high anxiety but approach the feared height, or vice versa — which is why multi-method assessment (AQ + BAT) is recommended.
• Recent RCT evidence (2025–2026) continues to validate these instruments in VR-based treatment paradigms (PMID: 40697772, PMID: 41775020).

Acrophobia Testing for Working-at-Heights Jobs (Construction/Industrial)

Why It's Required

The Full Assessment Battery

1. Medical History Questionnaire (Pre-Employment)

• History of anxiety disorders, vertigo, or phobias
• Medications (some cause dizziness/drowsiness — disqualifying for heights)
• Past head injuries, inner ear problems, or balance disorders
• Self-reported fear of heights

2. Physical Medical Examination

3. Psychological / Acrophobia-Specific Assessment

a) Psychometric Questionnaires

• Acrophobia Questionnaire (AQ) — Cohen, 1977: The standard self-report tool with 20-item anxiety subscale (0–6 scale) and 20-item avoidance subscale. Used clinically but also adopted in occupational settings to quantify severity.
• General Anxiety Screening (GAD-7): Brief 7-item scale; elevated scores prompt deeper evaluation.
• IAPT Phobia Scale: Used in some NHS/UK occupational health pathways to screen phobic avoidance.

b) Structured Clinical Interview

• Situational anxiety responses
• Coping and decision-making capacity
• Any history of panic attacks at height
• Psychological insight and self-awareness

4. Behavioural Avoidance Test (BAT) / Practical Simulation Test ⬅ The Key Occupational Test

• Worker is taken to an actual elevated structure (scaffold, ladder, elevated platform)
• Required to perform basic tasks at height while wearing full PPE (harness, helmet, safety shoes)
• Examiner (occupational physician + safety officer) observes:
  • Physical response (trembling, freezing, gripping)
  • Vital signs before and after (BP, pulse, SpO₂)
  • Ability to walk, maintain balance, and follow instructions at height
  • Ability to complete a set task (e.g., walk a 200mm beam over a 5-metre span)

• A dedicated height simulation structure is constructed on-site
• Worker climbs to tested height in full PPE
• Must walk along a narrow beam (200mm wide) for a set distance
• Vital signs are measured before and after by a physician
• If any parameter (BP, pulse, behavior) is abnormal OR the worker refuses/panics → not cleared for WAH work
• Pass/fail with medical certification issued by attending physician

5. Fitness-for-Duty Outcome Categories

Legal/Regulatory Framework

• OSHA (USA): Does not mandate a specific acrophobia test, but employers have a general duty (29 CFR 1926.21) to ensure workers are capable of safely performing their assigned tasks. Fitness-for-duty is the employer's responsibility.
• UK (Work at Height Regulations 2005): Employers must ensure workers are "competent" — occupational health physicians include psychological fitness screening as part of working-at-height medicals, required annually.
• India (AERB/SG/IS-4): References vertigo/acrophobia testing in nuclear and refinery settings; structured simulation testing is mandated.

Key Practical Points

• Self-disclosure is not enough — Workers who believe they have acrophobia should inform their occupational health provider before testing, not during the practical test at height.
• Simulation tests > questionnaires for occupational clearance — a worker may score borderline on the AQ but perform safely in practice, or vice versa.
• Treatment can restore fitness — Workers who fail can undergo CBT or VR-based exposure therapy and be re-assessed. Failure is not necessarily permanent.
• Annual re-assessment is required in most jurisdictions because fear of heights can develop (or resolve) over time, especially after a near-miss or fall incident.